Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02280863 · ClinicalTrials.gov registry record · NA
Hybrid Closed-Loop Hotel Studies With Medtronic PID Controller
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02280863: Completed NA study, sponsored by Stanford University.
NCT02280863 is a NA study that has completed, run by Stanford University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02280863, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and efficacy of the Medtronic hybrid closed-loop (HCL) system utilizing the proportional-integral-derivative algorithm with insulin feedback (PID-IFB) optimized to function in a hybrid mode with closed-loop control operating during the day and night.
Interventions
- DEVICE Medtronic Hybrid Closed-loop System - Android Platform
- DEVICE Medtronic Hybrid Closed-loop Integrated System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02280863
The ClinicalTrials.gov registry entry for NCT02280863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medtronic Hybrid Closed-loop System - Android Platform is the first listed.
NCT02280863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02280863 about?
NCT02280863 is a clinical study titled "Hybrid Closed-Loop Hotel Studies With Medtronic PID Controller". The primary objective of this study is to evaluate the safety and efficacy of the Medtronic hybrid closed-loop (HCL) system utilizing the proportional-integral-derivative algorithm with insulin feedback (PID-IFB) optimized to function in a hybrid mode with closed-loop control operating during the da...
What is the current status of trial NCT02280863?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-07. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02280863?
The interventions under investigation include: Medtronic Hybrid Closed-loop System - Android Platform (DEVICE), Medtronic Hybrid Closed-loop Integrated System (DEVICE).
Who is sponsoring clinical trial NCT02280863?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.